Low Grade B Cell Lymphoma: What Does It Mean?
The diagnosis of a low grade B cell lymphoma is both a specific and a non-specific diagnosis that contains the following components:
What Is Low Grade B Cell Lymphoma? (Grade)
The classification of 'low grade B cell lymphoma' in lymphoma terms means that the lymphoma in question is indolent, or slow-growing. In the past, this has been expressed both as a number (grade 1 through grade 3), or merely as low grade B cell lymphoma (high grade being a rarely used term).
The most frequently diagnosed low grade B cell lymphoma subtype is typically found in people in their 50s and is called follicular lymphoma.
Cell Type
Lymphoma affects the blood's lymphocytes, and it can either affect the B cells or the T -cells. Lymphomas affecting the B cells are far more common than lymphomas affecting the T cells, amounting to about eighty to eighty-five percent of all lymphomas. They are also more treatable and have a better Low Grade B Cell Lymphoma prognosis, generally speaking, than T cell lymphomas.
Lymphoma Category
Although this diagnosis simply says 'low grade B cell lymphoma' one can readily infer that it is a non-Hodgkin's lymphoma, as opposed to a Hodgkin's lymphoma. The reason this can be safely inferred is because Hodgkin's lymphomas are not expressed in terms of grade or cell type.
Low Grade B Cell Lymphoma ICD10
The ICD-10-CM code is C85. 90 which can be used to indicate a diagnosis for reimbursement purposes.
Related Articles
- Follicular lymphoma survival rate
- Lymphoma treatment options
- Is lymphoma curable?
- Low Grade B Cell Lymphoma at Wikipedia
Photo: Pexels
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
